Cargando…

Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)

SIMPLE SUMMARY: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating instituti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Haeyoung, Kim, Heejung, Park, Won, Baek, Jong Yun, Ahn, Sung Ja, Kim, Mi Young, Park, Shin-Hyung, Lee, Ik Jae, Ha, Inbong, Kim, Jin Hee, Kim, Tae Hyun, Lee, Kyu Chan, Lee, Hyung-Sik, Kim, Tae Gyu, Kim, Jin Ho, Lee, Jong Hoon, Jung, Jinhong, Cho, Oyeon, Chang, Jee Suk, Kim, Eun Seog, Jo, In Young, Koo, Taeryool, Kim, Kyubo, Park, Hae Jin, Shin, Young-Joo, Ha, Boram, Kwon, Jeanny, Lee, Ju Hye, Moon, Sunrock
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694237/
https://www.ncbi.nlm.nih.gov/pubmed/33158245
http://dx.doi.org/10.3390/cancers12113261
_version_ 1783614931153715200
author Kim, Haeyoung
Kim, Heejung
Park, Won
Baek, Jong Yun
Ahn, Sung Ja
Kim, Mi Young
Park, Shin-Hyung
Lee, Ik Jae
Ha, Inbong
Kim, Jin Hee
Kim, Tae Hyun
Lee, Kyu Chan
Lee, Hyung-Sik
Kim, Tae Gyu
Kim, Jin Ho
Lee, Jong Hoon
Jung, Jinhong
Cho, Oyeon
Chang, Jee Suk
Kim, Eun Seog
Jo, In Young
Koo, Taeryool
Kim, Kyubo
Park, Hae Jin
Shin, Young-Joo
Ha, Boram
Kwon, Jeanny
Lee, Ju Hye
Moon, Sunrock
author_facet Kim, Haeyoung
Kim, Heejung
Park, Won
Baek, Jong Yun
Ahn, Sung Ja
Kim, Mi Young
Park, Shin-Hyung
Lee, Ik Jae
Ha, Inbong
Kim, Jin Hee
Kim, Tae Hyun
Lee, Kyu Chan
Lee, Hyung-Sik
Kim, Tae Gyu
Kim, Jin Ho
Lee, Jong Hoon
Jung, Jinhong
Cho, Oyeon
Chang, Jee Suk
Kim, Eun Seog
Jo, In Young
Koo, Taeryool
Kim, Kyubo
Park, Hae Jin
Shin, Young-Joo
Ha, Boram
Kwon, Jeanny
Lee, Ju Hye
Moon, Sunrock
author_sort Kim, Haeyoung
collection PubMed
description SIMPLE SUMMARY: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. In all RLN regions including supraclavicular lymph node, axillary lymph node, and internal mammary lymph node, the radiation dose to the RLN was higher in WBI+RNI plan than WBI plan. ABSTRACT: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. To compare target coverage between the participants, an isodose line equal to 90% of the prescribed dose was converted to an isodose contour (contour(90% iso))(.) The relative nodal dose (RND) was obtained using the ratio of RLN dose to the target dose. The Fleiss’s kappa values which represent inter-observer agreement of contour(90% iso) were over 0.68. For RNI, 6 institutions included axillary lymph node (ALN), supraclavicular lymph node (SCN), and internal mammary lymph node (IMN), while 18 hospitals included only ALN and SCN. The median RND between the WBI and WBI+RNI were as follows: 0.64 vs. 1.05 (ALN level I), 0.27 vs. 1.08 (ALN level II), 0.02 vs. 1.12 (ALN level III), 0.01 vs. 1.12 (SCN), and 0.54 vs. 0.82 (IMN). In all nodal regions, the RND was significantly lower in WBI than in WBI+RNI (p < 0.01). In this study, we could identify the nodal dose difference between WBI and WBI+RNI.
format Online
Article
Text
id pubmed-7694237
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76942372020-11-28 Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) Kim, Haeyoung Kim, Heejung Park, Won Baek, Jong Yun Ahn, Sung Ja Kim, Mi Young Park, Shin-Hyung Lee, Ik Jae Ha, Inbong Kim, Jin Hee Kim, Tae Hyun Lee, Kyu Chan Lee, Hyung-Sik Kim, Tae Gyu Kim, Jin Ho Lee, Jong Hoon Jung, Jinhong Cho, Oyeon Chang, Jee Suk Kim, Eun Seog Jo, In Young Koo, Taeryool Kim, Kyubo Park, Hae Jin Shin, Young-Joo Ha, Boram Kwon, Jeanny Lee, Ju Hye Moon, Sunrock Cancers (Basel) Article SIMPLE SUMMARY: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. In all RLN regions including supraclavicular lymph node, axillary lymph node, and internal mammary lymph node, the radiation dose to the RLN was higher in WBI+RNI plan than WBI plan. ABSTRACT: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. To compare target coverage between the participants, an isodose line equal to 90% of the prescribed dose was converted to an isodose contour (contour(90% iso))(.) The relative nodal dose (RND) was obtained using the ratio of RLN dose to the target dose. The Fleiss’s kappa values which represent inter-observer agreement of contour(90% iso) were over 0.68. For RNI, 6 institutions included axillary lymph node (ALN), supraclavicular lymph node (SCN), and internal mammary lymph node (IMN), while 18 hospitals included only ALN and SCN. The median RND between the WBI and WBI+RNI were as follows: 0.64 vs. 1.05 (ALN level I), 0.27 vs. 1.08 (ALN level II), 0.02 vs. 1.12 (ALN level III), 0.01 vs. 1.12 (SCN), and 0.54 vs. 0.82 (IMN). In all nodal regions, the RND was significantly lower in WBI than in WBI+RNI (p < 0.01). In this study, we could identify the nodal dose difference between WBI and WBI+RNI. MDPI 2020-11-04 /pmc/articles/PMC7694237/ /pubmed/33158245 http://dx.doi.org/10.3390/cancers12113261 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Haeyoung
Kim, Heejung
Park, Won
Baek, Jong Yun
Ahn, Sung Ja
Kim, Mi Young
Park, Shin-Hyung
Lee, Ik Jae
Ha, Inbong
Kim, Jin Hee
Kim, Tae Hyun
Lee, Kyu Chan
Lee, Hyung-Sik
Kim, Tae Gyu
Kim, Jin Ho
Lee, Jong Hoon
Jung, Jinhong
Cho, Oyeon
Chang, Jee Suk
Kim, Eun Seog
Jo, In Young
Koo, Taeryool
Kim, Kyubo
Park, Hae Jin
Shin, Young-Joo
Ha, Boram
Kwon, Jeanny
Lee, Ju Hye
Moon, Sunrock
Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)
title Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)
title_full Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)
title_fullStr Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)
title_full_unstemmed Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)
title_short Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)
title_sort comparison of dose distribution in regional lymph nodes in whole-breast radiotherapy vs. whole-breast plus regional lymph node irradiation: an in silico planning study in participating institutions of the phase iii randomized trial (krog 1701)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694237/
https://www.ncbi.nlm.nih.gov/pubmed/33158245
http://dx.doi.org/10.3390/cancers12113261
work_keys_str_mv AT kimhaeyoung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kimheejung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT parkwon comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT baekjongyun comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT ahnsungja comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kimmiyoung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT parkshinhyung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT leeikjae comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT hainbong comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kimjinhee comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kimtaehyun comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT leekyuchan comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT leehyungsik comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kimtaegyu comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kimjinho comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT leejonghoon comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT jungjinhong comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT chooyeon comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT changjeesuk comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kimeunseog comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT joinyoung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kootaeryool comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kimkyubo comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT parkhaejin comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT shinyoungjoo comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT haboram comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT kwonjeanny comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT leejuhye comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701
AT moonsunrock comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701